A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
Condition: Advanced Solid Tumor Interventions: Drug: Apatinib Mesylate; Drug: Repaglinide; Drug: Bupropion Sponsor: Jiangsu HengRui Medicine Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials